CANbridge Life Sciences Ltd.
4 clinical trials · Sponsor
◉ Watch CANbridge Life Sciences Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of CAN008 in Subjects With GBM (NCT05447195) | CANbridge Life Sciences Ltd. | 2021-10-10 |
| To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) (NCT03746288) | CANbridge Life Sciences Ltd. | 2018-11-20 |
| CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma (NCT03152708) | CANbridge Life Sciences Ltd. | 2017-11-01 |
Track CANbridge Life Sciences Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.